Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Steam treatment for enlarged prostate goes Head-to-Head with surgery

NCT ID NCT07587333

Symptom relief Sponsor: Beni-Suef University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compared two treatments for an enlarged prostate (BPH): a newer steam-based procedure called Rezum and a standard surgery called TUEP. Researchers measured how well each improved urinary symptoms, urine flow, and sexual function in 70 men over age 50. The goal was to see if the less invasive steam treatment could match surgery's effectiveness with fewer complications.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Rezum (convective radio-frequency water vapor energy) and TUEP (transurethral enucleation of the prostate)
What this could lead to
If successful, this could show that a less invasive steam procedure works as well as surgery for relieving BPH symptoms, with fewer side effects.
What could go wrong
This is a small, completed study with only 70 men. Results may not apply to everyone, and both procedures carry risks like infection or sexual side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

70 people

The number who actually took part.

Started

Mar 2025

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male aged \> 50 yrs. * International Prostate Symptom Score (IPSS) \>12 * Maximum flow rate ( Qmax ) \< 15 ml/s for 125ml voided volume * Post-void residual volume \<350 ml * Prostate volume 80-120 g Exclusion Criteria: * Active urinary tract infection at time of treatment. * Prostate-specific antigen (PSA) more than 10 ng/l. * history of prostate or bladder cancer. * Anticoagulants within 3d of the index procedure

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BPH (benign prostatic hyperplasia) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BPH (benign prostatic hyperplasia)

Contacts and locations

Locations

  • Faculty of medicine Beni Suef University

    Banī Suwayf, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.